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Uracil-DNA glycosylase (UNG) is the key enzyme responsible for
initiation of base excision repair. We have used both kinetic and
binding assays for comparative analysis of UNG enzymes from
humans and herpes simplex virus type 1 (HSV-1). Steady-state flu-
orescence assays showed that hUNG has a much higher specificity
constant (kcat/Km) compared with the viral enzyme due to a lower
Km. The binding of UNG to DNA was also studied using a catalyti-
cally inactive mutant of UNG and non-cleavable substrate analogs
(2-deoxypseudouridine and 2--fluoro-2-deoxyuridine). Equi-
librium DNA binding revealed that both human and HSV-1 UNG
enzymes bind to abasic DNA and both substrate analogs more
weakly than to uracil-containing DNA. Structure determination of
HSV-1D88N/H210NUNG in complexwith uracil revealed detailed
information on substrate binding. Together, these results suggest
that a significant proportion of the binding energy is provided by
specific interactions with the target uracil. The kinetic parameters
for humanUNG indicate that it is likely to have activity against both
UA and UGmismatches in vivo. Weak binding to abasic DNA also
suggests that UNG activity is unlikely to be coupled to the subse-
quent common steps of base excision repair.
Uracil-DNA glycosylase (UNG)3 is the primary enzyme responsible
for the removal of uracil from DNA. Uracil can arise in DNA either by
themisincorporation of dUTP duringDNA synthesis, which results in a
UA base pair, or by the spontaneous deamination of cytosine. Approx-
imately 100 cytosine deamination events cell1 day1 are expected in
human cells (1), producing a promutagenic UG mismatch in DNA. If
unrepaired, this will lead to an AT transition mutation following DNA
replication.
UNG is one of the initiating DNA glycosylases of the base excision
repair pathway and is responsible for the specific recognition and
removal of uracil. It removes uracil by cleavage of theN-glycosidic bond
between the uracil and the deoxyribose backbone, leaving an apyrimi-
dinic (AP) site (2). AP sites are themselves highly mutagenic and are
further repaired by the common downstream enzymes of the base exci-
sion repair pathway (3). The first common repair step is an AP endonu-
clease, which cleaves the DNA backbone at the abasic site (4).
UNG enzymes have been identified in a wide variety of organisms,
including human, Escherichia coli, and herpes simplex virus type 1
(HSV-1). They are well conserved; theHSV-1 and human enzymes have
39% sequence identity, whereas the HSV-1 and E. coli enzymes are 49%
identical. They are also highly conserved at the structural level (5–7).
The structure of human (h) UNG in complex with DNA has revealed
that it binds uracil by flipping the target nucleotide out of the double
helix and into the active-site pocket (6, 8). The DNA-binding pocket of
UNG is highly specific for uracil in DNA. Other DNA bases and uracils
in RNA are excluded from this DNA-binding pocket due to unfavorable
steric and hydrogen bond interactions (5, 6).
A number of previous studies on both the human and HSV-1 UNG
enzymes have indicated possible differences in their catalytic behavior.
Notably, hUNG has been reported to bind tightly to its abasic product
DNA, and it has been proposed that the action of hUNG is coupled to
the common base excision repair steps via AP endonuclease (9). In
comparison, HSV-1UNGhas been observed to bind product DNAonly
weakly (10, 11), making coupling of these two events unlikely in the viral
enzyme. Furthermore, hUNGhas been cited as having a higherKm value
(8, 12, 13) thanwe observed forHSV-1UNG (10), and this has informed
the description of hUNG as having a single function in post-replicative
repair of UA mismatches (14).
In light of these reported differences between the viral and human
UNG enzymes, we decided to investigate both enzymes in kinetic and
DNA binding studies. The objective was to precisely identify any differ-
ences between these two highly related DNA repair enzymes, with a
view to further defining their functional roles as well as exploring the
potential of viral UNG as a therapeutic target. A previous report has
indicated that nucleotide analogsmay provide specific inhibitors for the
HSV-1 enzyme (15).We therefore wished to investigate the DNA bind-
ing of both human and HSV-1 UNG enzymes to non-cleavable sub-
strate analogs both as a probe to investigate protein-DNA interactions
and to further explore the possibility of finding specific inhibitors of
viral UNG.
We investigated the catalytic rates and DNA binding properties of
both wild-type and mutant forms of human and viral UNG using both
biochemical and biophysical assays. These included quench reactions to
monitor the rate of N-glycosyl hydrolysis and a fluorescence assay to
follow steady-state reactions. Furthermore, the binding of the human
and HSV-1 UNG enzymes to substrate DNA and abasic product DNA
was examined by fluorescence anisotropy. Catalytically inactive mutant
enzymes were used in studies of the binding of UNG to uracil-contain-
ing substrates. In addition, the binding activity of wild-type UNG was
measured using the non-hydrolyzable substrate analogs 2-deoxy-
pseudouridine (drd) and 2--fluoro-2-deoxyuridine (-FdUrd).We
also performed crystallographic analysis of HSV-1 mutant UNG to
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compare the active-site structure and mode of uracil binding to the
wild-type enzyme.
MATERIALS ANDMETHODS
Plasmid Constructions—HSV-1 wild-type UNG was prepared using
the recombinant plasmid pTS106.1 (5). Site-directed mutagenesis was
carried out on pTS106.1 to construct the HSV-1 D88N and H210N
UNG single mutants. The HSV-1 D88N/H210N UNG double mutant
was constructed by cloning an XbaI fragment of the pH210N plasmid,
which contains the H210N mutation, into the pD88N plasmid. All
mutants were verified by sequencing.
The recombinant hUNG plasmid pUNG15 was purchased from
American Type Culture Collection. The truncated hUNG gene encod-
ing amino acids 84–304 of hUNGwas subcloned into expression vector
pRSET-B (Invitrogen) using NcoI/HindIII restriction sites. The DNA
fragment encoding the enterokinase recognition site located between
the N-terminal polyhistidine tag and the truncated hUNG gene was
deleted by NcoI/NheI digestion, fill-in reaction (16), and plasmid reli-
gation, resulting in pHUNG4. The D145N and H268N mutations were
introduced into pHUNG4 by site-directed mutagenesis. Human
D145N/H268N UNG was subsequently generated by site-directed
mutagenesis using the plasmid containing the D145N hUNG gene as a
template. All mutants were verified by sequencing.
Protein Overexpression and Purification—HSV-1 UNG was overex-
pressed and purified as described previously (10). The D88N, H210N,
and D88N/H210Nmutant enzymes were expressed and purified from a
construct in exactly the same manner. hUNG and its mutant enzymes
were expressed inE. coliBH156. The cultures were grown in LB broth at
37 °C to A600  0.8 before induction with 1 mM isopropyl 1-thio--D-
galactopyranoside. The cultures were grown for an additional 3 h at
37 °C before the cells were harvested. The harvested cells were lysed by
sonication in buffer containing 20 mM Tris (pH 7.6), 50 mM imidazole,
300 mM NaCl, and a tablet of EDTA-free protease inhibitors (Roche
Applied Science). The lysate was clarified by centrifugation at 40,000
rpm for 45 min. The clarified lysate was loaded onto a nickel-Sepharose
column equilibrated in 20 mM Tris (pH 7.6), 50 mM imidazole, and 300
mMNaCl. After washing, the UNG enzymewas eluted from the column
with a gradient of 50–500mM imidazole. The fractions were assayed by
SDS-PAGE, and those containing UNG were pooled and concentrated
by ultrafiltration. The concentrated fractions were diluted with 20 mM
Tris (pH 7.6), 1 mM EDTA, and 10% glycerol so that the NaCl concen-
tration was0.02 M. The partially purified protein was then applied to
a poly(U)-Sepharose affinity column equilibrated in 20 mM Tris (pH
7.6), 1 mM EDTA, and 10% glycerol; and after washing, the UNG
enzymewas elutedwith a gradient of 0–1MNaCl. The pure enzymewas
then concentrated by ultrafiltration. The concentration of the protein
was calculated from the absorbance at 280 nm based on an extinction
coefficient of 48.9 103 M1 cm1.
DNA Synthesis and Purification—Oligodeoxynucleotides were syn-
thesized by MWG Biotech. All modifications were incorporated into
oligonucleotides at the point of synthesis using conventional phos-
phoramidite chemistry. The phosphoramidites of 2-dUrd, drd,
-FdUrd, 2-aminopurine (2-AP), and hexachlorofluorescein were also
supplied by MWG Biotech. Oligonucleotides were purified by high
pressure liquid chromatography as described previously (17). Double-
stranded substrates and abasic oligonucleotides weremade as described
previously (10).
Kinetic Assays—Steady-state fluorescence spectra were measured on
a HORIBA Jobin Yvon FluoroMax 3 spectrofluorometer. The 2-AP flu-
orescencewas recordedwith an excitationwavelength of 310 nmand an
emission wavelength of 370 nm using a 5-mm cuvette. Steady-state
fluorescence assays were performed at 25 °C in 50 mM Tris-HCl (pH
7.6), 1mMEDTA, 50mMNaCl, 0.1mgml1 bovine serum albumin, and
2 mM MgCl2 using the hUNG enzyme to give a final concentration of
0.5, 1.0, or 2.0 nM. The endpoint of the reaction was determined by
addition of the second aliquot of high concentration UNG. The initial
velocity (M s1) was then calculated from the initial linear progression
in fluorescence and the total change in fluorescence. The rate (s1) was
calculated by dividing the initial velocity by the total enzyme
concentration.
Single turnover quench reactions were performed at 25 °C with 32P-
labeledUrd substrate (0.1M; seeTable 1) andmutantUNGenzymes (1
M) in standard reaction buffers (HSV-1 UNG: 50 mM Tris-HCl (pH
8.0), 1 mM EDTA, 150 mM NaCl, and 0.1 mg ml1 bovine serum albu-
min; and hUNG: 50 mM Tris-HCl (pH 7.6), 1 mM EDTA, 50 mM NaCl,
and 0.1 mg ml1 bovine serum albumin). The assay was otherwise per-
formed as described previously (18).
Competitive DNA Binding Assays—Competitive equilibrium DNA
binding assays were performed by fluorescence anisotropy using the
FluoroMax 3 spectrofluorometer fitted with automated polarization fil-
ters. Data were recorded using an excitation wavelength of 530 nm and
an emission wavelength of 555 nm. The binding assays were conducted
at 25 °C in reaction buffer by titrating increasing concentrations of the
unlabeled ssU oligonucleotide into a fixed concentration of the fluores-
cent HU oligonucleotide and D88N/H210N UNG. Data were analyzed
following the method of Reid et al. (19) using the program Scientist
(MicroMath Research).
EquilibriumDNA Binding Assays—EquilibriumDNA binding assays
were performed by fluorescence anisotropy using the same spectro-
scopic settings described above to examine the binding of the wild-type
and mutant UNG enzymes to the 5-hexachlorofluorescein-labeled oli-
gonucleotides (Table 1). The binding assays were conducted at 25 °C in
reaction buffer by titrating fixed concentrations of the fluorescent DNA
with increasing amounts of the enzyme. The observed anisotropy was
plotted against the concentration of enzyme, and the data were fitted to
the quadratic binding equation (Equation 1) using GraFit Version 5.0,
A  AD ADE AD Kd 	E
0 	DNA
T Kd
 	E
0 	DNA
T
2 4	E
0	DNA
T/2	DNA
T (Eq. 1)
where [DNA]T is the concentration of DNA used in each experiment,A
is the observed anisotropy,AD is the anisotropy for free DNA,ADE is the
anisotropy for enzyme-bound DNA, Kd is the equilibrium dissociation
constant, and [E]0 is the total enzyme concentration.
Crystallization, Data Collection, and Structure Determination and
Refinement—Crystals of HSV-1 D88N/H210N UNG were obtained in
microbatch experiments at 25 °C at 30 mg ml1 protein in 6% polyeth-
ylene glycol 4000 and 40 mM imidazole (pH 6.8). The D88N/H210N
UNG-uracil complexes were obtained by soaking native crystals in 11%
polyethylene glycol 4000, 42mM imidazole (pH6.8), and 20mM2-dUrd
(Sigma) for 16 h.
Diffraction data were collected on a Quantum 4 CCD detector (Area
Detection Systems Corp.) with 0.978-Å radiation on beamline 9.6 of the
Daresbury Synchrotron Radiation Source (Cheshire, UK). Diffraction
imageswere processed usingDenzo and Scalepack (HKLResearch, Inc).
Parameters for the data collection and processing are given in Table 2.
The structure of HSV-1D88N/H210NUNGwas determined bymolec-
ular replacement using molrep (20) and the structure of HSV-1 wild-
type UNG (Protein Data Bank code 1UDG) as a search model. The best
molecular replacement solution gave a correlation coefficient of 0.470
Human and HSV-1 Uracil-DNAGlycosylase
4984 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 8•FEBRUARY 24, 2006
 at B
IR
K
B
ECK
 CO
LLEG
E on M
ay 14, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and an R-factor of 0.438, with corresponding values for the next highest
peak of 0.252 and 0.528. The protein model transformed by the molec-
ular replacement solution was refined against the observed diffraction
data using CNS (21). The Fo Fc maps reveal electron density features
consistent with the Asn210 and Asn88 mutations.
Subsequent cycles of manual model building were performed using
the program O (22). The structure of D88N/H210N UNG was further
refined by stereochemically restrained simulated annealing and posi-
tional refinement with the program CNS (21). Ordered solvent mole-
cules were placed into Fo Fcmaps using the programARP/wARP (23).
Progress was monitored throughout by the consistent decrease in the
crystallographic R-factor and verified by cross-validation by a corre-
sponding decrease in Rfree. The quality of the refined model was deter-
mined using the programs PROCHECK (24) and WHATCHECK (25).
The refinement statistics of D88N/H210N UNG are shown in Table 2.
Data for HSV-1 D88N/H210N UNG in complex with uracil were
collected on the Quantum 4 CCD detector with 0.87-Å radiation on
beamline 9.6 of theDaresbury Synchrotron Radiation Source. The com-
plex crystal had the same space group as the native crystal. Data collec-
tion statistics are shown in Table 2. The structure of D88N/H210N
UNG in complex with uracil was determined bymolecular replacement
using molrep (20) and the structure of native D88N/H210N UNG as a
search model. The correct solution gave the highest correlation coeffi-
cient of 0.507 and anR-factor of 0.400, with corresponding values for the
next solution of 0.336 and 0.501, respectively. Themodel of the complex
was refined and rebuilt as described above. The Fo  Fc maps indicate
the presence of a uracil base in the active site of UNG. The uracil was
constructed and refined with the protein model using CNS (21). The
final model gave refinement statistics as shown in Table 2.
RESULTS
Steady-state Analysis—Steady-state reactions were performed with
hUNG to determine its kinetic parameters under the same conditions
that had been previously used for HSV-1 UNG (10). The fluorescent
base analog 2-AP was used to monitor the kinetics of glycosidic bond
cleavage by incorporation next to a uracil base in oligonucleotide sub-
strates (Table 1). Because the quantum yield of 2-AP is very sensitive to
its environment and displays strong quenching when stacked in DNA
(26), removal of the uracil base adjacent to 2-AP by UNG results in a
large increase in fluorescence (27). We have previously demonstrated
that incorporation of 2-AP does not affect the binding of the UNG
enzyme to the oligonucleotide (10).
hUNG reactions were performedwith a single-stranded oligonucleo-
tide substrate (1U) and double-stranded forms of the substrate contain-
ing either a UG mismatch or a UA base pair (1UG and 1UA, respec-
tively). The rate constants showed a hyperbolic dependence upon the
substrate concentration, and the data were fitted to theMichaelis-Men-
ten equation (Fig. 1), giving the steady-state parameters kcat andKm.We
also determined that removal of theN-terminalHis tag fromhUNGhad
no impact on the catalytic constants (data not shown). The kinetic
parameters for hUNG with different substrates are shown compared
with those for HSV-1 UNG (Table 3) (10). The kinetic data show an
8–50-fold higher kcat/Km value for hUNG compared with that for
TABLE 1
Substrates used in kinetic and equilibrium binding assays
The chromophore hexachlorofluorescein (HEX) was incorporated at the 5-end
during synthesis. The double-stranded substrates (HUGandHAP:G)weremade by
annealing the appropriate strands.
Oligonucleotide Sequence
Steady-state fluorescencea
1U 5-GAC TAP UAA TGA CTG CG-3
1UG 5-GAC TAP UAA TGA CTG CG-3
3-CTG ATT GTT ACT GAC GC-5
1UA 5-GAC TAP UAA TGA CTG CG-3
3-CTG ATT ATT ACT GAC GC-5
Single turnover assaysb
ssU 5-GAC TAA UAA TGA CTG CG-3
Binding assays
HU (U 2-dUrd) 5-(HEX) GAC TAA UAA TGA CTG CG-3
HUG (U 2-dUrd) 5-(HEX) GAC TAT UAA TGA CTG CG-3
3-CTG ATA GTT ACT GAC GC-5
HAP (X abasic) 5-(HEX) GAC TAA XAA TGA CTG CG-3
HAPG (X abasic) 5-(HEX) GAC TAT XAA TGA CTG CG-3
3-CTG ATA GTT ACT GAC GC-5
drd (X drd) 5-(HEX) GAC TAA XAA TGA CTG CG-3
-FdUrd (X -FdUrd) 5-(HEX) GAC TAA XAA TGA CTG CG-3
a Oligonucleotides for steady-state fluorescence assays were synthesized with 2-AP
(P) incorporated next to the uracil base (1U). The double-stranded substrates
(1UG and 1UA) were made by annealing the appropriate strands.
b The oligonucleotide for single turnover assays was 5-labeled with 32P.
TABLE 2
Crystallographic statistics
The Protein Data Bank accession codes are 2C56 for HSV-1 D88N/H210NUNG and 2C53 for HSV-1 D88N/H210NUNGwith dUrd. r.m.s.d., root mean square deviation.
Crystals
D88N/H210N UNG D88N/H210N UNG-uracil complex
Data collection
Resolution (Å) 30.0 to 2.1 15.0 to 1.8
Space group P21 P21
Unit cell dimensions a 42.04, b 61.117,
c 43.392,  90,  92.251,  90
a 42.406, b 61.161,
c 43.620,  90,  93.15,  90
Measured reflections 47,672 63,757
Unique reflections 12,927 19,411
Overall completeness 99.9 93.7
High resolution shell 100 (2.18 to 2.10) 63.1 (1.86 to 1.80)
Overall Rmerge 8.5 7.5
High resolution shell 22.0 25.8
Overall I/	 12.5 13.8
Highest resolution shell I/	 5.3 2.3
Structure refinement
No. of working reflections 12,266 18,435
No. of free reflections 646 961
R-factor (%) 0.1507 0.1641
Rfree (%) 0.2118 0.2157
Average B-factor 14.235 16.177
No. of atoms 2102 2112
r.m.s.d. bond distances (Å) 0.016 0.017
r.m.s.d. bond angles 1.699° 1.683°
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HSV-1 UNG. This represents a significantly increased catalytic effi-
ciency for hUNG.
Active-siteMutations—The active site of UNGcontains catalytic Asp
and His residues that are highly conserved throughout all UNG
enzymes and that have been demonstrated to be involved in catalysis (5,
6, 28). We have made Asn mutations for both of these residues, both
singly and in combination for the human andHSV-1UNG enzymes, for
the purpose of generating inactive mutant enzymes for DNA binding
studies. Furthermore, we intend to explore the role of these residues in
catalysis and substrate binding.
The activity of the UNG mutants was monitored under single turn-
over conditions using the quench assay with the 32P-labeled ssU oligo-
nucleotide (18). Under these conditions, the substrate is in excess over
the enzyme; and hence, only a single turnover of the reaction occurs:
under saturating conditions, the accumulation of product corresponds
directly to the rate of N-glycosidic bond cleavage. The observed rate of
cleavage (kobs) was determined by fitting the accumulation of product to
either a single exponential or a linear equation.
Reactions were performed under saturating conditions with a 10-fold
excess of the single mutant UNG enzymes (human D145N and H268N
andHSV-1D88N andH210N) over the 32P-labeled substrate. The reac-
tions demonstrated that the singlemutants of UNGcontain some resid-
ual activity (Fig. 2). However, the human D145N/H268N and HSV-1
D88N/H210N UNG double mutants showed no UNG activity even
after 24 h with a 10-fold excess of the enzyme (data not shown).
Equilibrium DNA Binding—To prevent turnover of substrate in
DNA binding experiments, it is necessary to use either inactive enzyme
mutants or substrates that are refractory to cleavage. In this study, we
used both approaches. As described above, the human D145N/H268N
and HSV-1 D88N/H210N UNG double mutants had no activity even
after 24 h under standard reaction conditions and are thus suitable for
use in DNA binding studies. In addition, the humanH268N and HSV-1
H210N UNG enzymes were deemed sufficiently inactive to be used in
binding assays with uracil-containing substrates. However, the human
D145N and HSV-1 D88N UNG single mutants had sufficient residual
activity that they could be used only with the non-cleavable substrate
analogs and abasic product DNA.
We used two non-cleavable substrate analogs (drd and -FdUrd).
The pucker of the ribose sugar is largely determined by the electronega-
tivity of the 2-substituent; hence, RNA has a C-3-endo sugar pucker,
whereas DNA has a C-2-endo sugar pucker (29). Similarly, both the -
and -2-fluorouridine derivatives favor the C-3-endo pucker (30–32).
The -isomer has been suggested to be the better uridine analog (33); in
2-AP fluorescence binding assays with E. coli UNG, it gave a stronger
signal; although the -isomer was also observed to be bound by this
enzyme, a Kd was not reported for this isomer. The -isomer has also
been reported to be a specific inhibitor of HSV-1 UNG (15). In this
study, we used the commercially available -isomer.
The binding of DNA by UNG has been observed using 5-hexachlo-
rofluorescein-labeled DNA substrates.When proteins bind the fluores-
cently labeled DNA, it leads to a change in the rotational diffusion of the
fluorophore due to the change in the molecular mass of the protein-
DNAcomplex relative to freeDNA.This in turn results in an increase in
fluorescence anisotropy and has been shown to be an ideal method
for monitoring the binding of DNA by proteins in solution (34). The
advantage of this technique is that the DNA is free to move in solu-
tion.Moreover, the fluorescence reporter group is far removed from the
target uracil and thus provides a measure of DNA binding that is inde-
pendent of other conformational transitions associated with damage
recognition.
It is of course important to determine that the hexachlorofluorescein
reporter group does not interfere with DNA binding by UNG.We have
therefore examined this by performing a competition binding experi-
ment. SufficientHSV-1D88N/H210NUNGwasmixedwith the labeled
HU oligonucleotide to form an enzyme-DNA complex, and the labeled
DNA was then competed away with the unlabeled ssU oligonucleotide.
This resulted in a decrease in the observed anisotropy, which could be
fitted to a competitive bindingmodel following themethoddescribed by
Reid et al. (19). This gave a Kd of 4.9 nM for the unlabeled ssU oligonu-
cleotide (Fig. 3), compared with a Kd of 10 nM for the hexachlorofluo-
rescein-labeled HU oligonucleotide (Table 4; see below). This demon-
strates that the hexachlorofluorescein reporter group does not interfere
with DNA binding by UNG for the substrates used in this study.
TABLE 3
Comparison of steady-state data of the human and HSV-1 UNG enzymes
Steady-state reactions were performed with the substrates shown in Table 1 using fluorescence assays. The kinetic parameters were obtained by fitting data to the
Michaelis-Menten equation. The parameters kcat and Km for HSV-1 UNG are from Bellamy and Baldwin (10).
Substrate hUNG HSV-1 UNGkcat Km kcat/Km kcat Km kcat/Km
s1 M M s1 s1 M M s1
1U 13.9 0.7 0.22 0.04 63 15 6.7 0.3 0.9 0.1 7.1 1.1
1UG 8.0 0.3 0.1 0.02 74 19 2.4 0.2 0.9 0.2 2.7 0.8
1UA 7.4 0.4 0.12 0.02 67 14 2.1 0.1 1.6 0.2 1.3 0.2
FIGURE 1. Steady-state analysis of hUNG. Steady-state reactions were performed by
monitoring the fluorescence of 2-AP-containing substrates (see “Materials and Meth-
ods”) after addition of hUNG. Rates were determined from the initial increase in fluores-
cence at different concentrations of substrates and normalized for enzyme concentra-
tion. The observed rates are shown plotted against concentration for the substrates 1U
(F), UG (Œ), and UA (f). The data are shown with the best fit to the Michaelis-Menten
equationwith the following values: 1U(OO), kcat 13.9 0.7 s
1 and Km 0.22 0.04
M; 1UG (– – –), kcat 8.0 0.3 s
1 and Km 0.12 0.02M; and 1UA (), kcat 7.4
0.4 s1 and Km 0.1 0.02 M.
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Direct binding isotherms were obtained by titrating increasing con-
centrations of enzyme into a fixed concentration of different fluorescent
substrates (Table 1). The dissociation constant (Kd) was then deter-
mined by plotting the resulting change in anisotropy versus enzyme
concentration and fitting the data to the quadratic binding equation
(Equation 1 under “Materials and Methods”). It should be noted that
this equation is free from errors that can arise when the total enzyme
concentration is not equal to the free enzyme concentration and so can
be used under tight binding conditions.
The inactive human D145N/H268N UNG enzyme produced a tight
binding curve with both the single- and double-stranded uracil-con-
taining substrates (HU and HUG) (Fig. 4A). When the wild-type
enzyme was examined with the abasic DNAs, the binding was found to
be 2 orders of magnitude weaker (Fig. 4B). Similar results were also
found with the human H268N UNG single mutant (Table 4).
Binding of Substrate Analogs—DNA binding was also investigated
with the wild-type and mutant hUNG enzymes and the non-cleavable
substrate analogsrd and-FdUrd. The wild-type enzyme bound both
rd and -FdUrd DNAs 2 orders of magnitude more weakly com-
pared with the mutant enzymes with uracil-containing DNA (Fig. 5A).
We therefore considered that this discrepancy could be due to two
causes: the mutant UNG enzymes might bind uracil-containing DNA
anomalously tightly; alternatively, the mutants may bind DNA in a very
similar manner to the wild-type enzyme, but the non-cleavable analogs
that we tested are not good substrate mimics. Intriguingly, a strain
hypothesis has been previously proposed forUNG (35), and it is possible
that the wild-type enzyme might bind its substrate more weakly com-
pared with a mutant that is unable to exert any strain on the substrate.
This hypothesis was therefore tested by examining the binding of the
mutant hUNG enzymes with the non-cleavable substrate analogs rd
and -FdUrd. The human D145N/H268N UNG double mutant bound
both substrate analogs with a weak affinity similar to that observed with
the wild-type enzyme (Fig. 5B). Experiments were also performed with
the human D145N and H268N UNG single mutants. In both cases,
similar weak binding affinities were also observed (Table 4). This there-
fore indicates that the inability ofUNG to bindrd and-FdUrd tightly
is not due to substrate strain because the mutants, which bound the
uracil-containing DNA substrates tightly, bound the DNA analogs
weakly. The mutants thus appear to be unable to bind the bases ofrd
and -FdUrd in the same manner in which they bind the uracil base in
the HU and HUG oligonucleotides. Indeed, it is striking that the bind-
ing affinities of the analog DNAs closely resemble those observed with
the abasic product DNA, and it is possible that the DNA binding with
rd and -FdUrd is due to nonspecific interactions with the DNA
backbone.
We also extended our previous work on DNA binding by HSV-1
UNG to include the substrate analogs and thus further explore this issue
as well as the relatedness of the human and HSV-1 UNG enzymes. The
equivalent active-site mutations were investigated with the substrate
analog DNAs rd and -FdUrd. In all cases, HSV-1 UNG exhibited
FIGURE 2.Single turnover analysis of singlemutantUNGenzymes.Quench reactions
were performed with a 10-fold excess of the mutant enzymes over the 32P-labeled ssU
substrate (1 M mutant UNG to 0.1 M ssU substrate), with the other conditions as
described under “Materials and Methods.” A, data for the human D145N (F) and H268N
(Œ) UNG singlemutants are shownwith thebest fit to a single exponential equationwith
the following values: humanD145NUNG, kobs 3.3 10
3 4 104 s1; and human
H268NUNG, kobs (4.0 2) 10
4 s1. B, data for HSV-1D88NUNG (F) are shownwith
the best fit to a single exponential equationwith kobs 2.7 10
3 4 104 s1. Data
for HSV-1 H210N UNG are shown (Œ) with the best fit to a linear equation. An estimated
kobs for HSV-1 H210N UNG was calculated from the linear gradient (M
1 s1) and nor-
malized to the total enzyme concentration with kobs 8.6 10
5 4 106 s1.
FIGURE 3. Competitive DNA binding. A competitive binding experiment was per-
formed by mixing HSV-1 D88N/H210N UNG (0.12 M) with the HU oligonucleotide (0.1
M). The fluorescence anisotropy was thenmeasured as the unlabeled ssU oligonucleo-
tide was titrated in up to 2.0M. The data are shownwith the best fit to the competitive
binding model (see “Materials and Methods”) with the following values: total DNA con-
centration 0.1 M; total enzyme concentration 0.12 M; anisotropy of free DNA
0.051; anisotropy of boundDNA 0.113; Kd for labeledHUDNA 0.01M (Table 4); and
Kd1 for unlabeled ssU competitor DNA 0.0049 M.
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exactly the same behavior as its human counterpart (Table 4): tight
binding ofmutant enzymes to uracil-containingDNAandweak binding
of wild-type and mutant enzymes to product DNA and both substrate
analogsrd and -FdUrd.
Energetic Analysis of DNA Binding—The equilibrium dissociation
constants determined above can be considered in energetic terms
because the dissociation constant provides a measure of the Gibbs free
energy for the binding reaction according to Equation 2,
G  RT ln1/Kd (Eq. 2)
where R is the gas constant (1.987 cal degree1 mol1).
The binding of human D145N/H268N UNG to the single-stranded
HU oligonucleotide has a free energy of10.6 kcal mol1. The equiva-
lent abasic oligonucleotide has aG of7.4 kcal mol1. The absence of
the uracil base thus leads to a G of 3.2 kcal mol1, which is a
significant proportion of the binding energy. A more modest loss in
binding energy of1.2 kcal mol1 was observed upon going from sin-
gle- to double-stranded DNA (HU versus HUG), which is most likely
due to the distortions that the enzyme must exert on the DNA. How-
ever, with the abasic DNAs, therewas no loss of binding energy between
single- and double-stranded forms (HAP versus HAPG), suggesting
that the DNA is less distorted in the enzyme-product complex. These
values are remarkably consistent across both the human and HSV-1
UNG enzymes.
Further analysis of binding energies between the wild-type and single
and double mutant forms of the human andHSV-1 UNG enzymes with
rd and -FdUrd analogs did not reveal any significant coupling of
binding energy between these two mutations: for hUNG withrd, the
coupling energy (G) between the D145N and H268N mutations is
0.62 kcal mol1. The absence of any negative coupling energy implies
that these catalytic residues do not cooperate in straining the substrate
prior to catalysis. Alternatively, UNGmay not be able to fully flip these
base analogs into the active site, so they may not be able to interact with
the catalytic residues.
Structural Comparison of the HSV-1 Wild-type and D88N/H210N
UNG Enzymes—The DNA binding data presented above indicate that
the mutant enzymes bind uracil-containing DNA tightly, whereas aba-
sic product DNA is boundweakly. To further explore themechanism of
base recognition by mutant UNG compared with wild-type UNG, we
used x-ray crystallography to investigate these interactions at the
atomic level.
The crystal structure of free HSV-1 D88N/H210N UNG was refined
to 2.1-Å resolution. The structure lacks electron density for the first 16
amino acid residues, and these residues are presumed to be disordered
in the crystal. This phenomenon is also observed in theHSV-1wild-type
UNG crystal (5). Superimposition of the mutant structure with that of
HSV-1 wild-type UNG indicates that the double mutation of Asp88 and
His210 to Asn caused nomajor changes in either the overall structure or
the positions of critical amino acid residues involved in the formation of
the uracil-binding pocket (Fig. 6A).
Electron density maps reveal that the His residue in the active site
(His210) was successfully mutated to asparagine and adopted the same
conformation. Amino acid 88 in D88N/H210N UNG adopted a differ-
ent orientation in comparison with Asp88 in the wild-type enzyme (Fig.
6A). The Asn88 side chain in D88N/H210N UNG is turned away from
the active site, whereas theAsp88 side chain inwild-typeUNG is pointed
toward the active site. The position of the Asn88 side chain in theD88N/
H210N UNG crystal is similar to the Asp88 side chain in the trinucle-
otide complex crystal (5), where Asp88 is rotated away from deoxythy-
midine, and this orientation is presumed to be involved in the rejection
of thymidine as a substrate (5). Consistent with this, the position of the
side chain of Asn88 is most likely a factor causing a decrease in the
activity of D88N UNG.
The crystal structure of HSV-1 D88N/H210N UNG soaked with uri-
dine has been solved to 1.8-Å resolution. Electron density maps show
that there is electron density corresponding to the N-glycosidic bond,
consistent with the lack of catalytic activity observedwith thismutant in
biochemical assays (Fig. 3). Some disordered density is observed in the
region of the deoxyribose. The disordering is most likely due to rotation
around theN-glycosidic bond and possibly also to fragmentation of the
labile deoxyribose by high intensity ionizing radiation during data
collection.
The D88N/H210N UNG-uracil complex structure reveals that the
uracil is bound in exactly the same position as in the binding pocket of
the wild-type enzyme (Fig. 6B). The uracil contributes a number of
hydrogen bonds with amino acid residues in the binding pocket (Fig.
6C). These interactions in HSV-1 D88N/H210N UNG are similar to
those in the wild-type enzyme (Fig. 6C). The rotation of Asn88 away
from the position of Asp88 in the wild-type structure does not affect the
binding of the uracil, nor does the mutation of His210 to Asn. These
results clearly demonstrate that HSV-1 D88N/H210N UNG binds ura-
cil in the same manner as the wild-type enzyme.
We also attempted to solve the structure of the rd nucleotide in
complex with UNGwith the objective of investigating the atomic inter-
actions of this analogwith the active site of the enzyme. The structure of
hUNG has been previously solved in complex with an oligonucleotide
containingrd, and a distorted conformation of theN-glycosidic bond
was observed (35). Here, wewere concerned primarily with interactions
TABLE 4
Equilibrium binding
The dissociation constants (Kd) for the human and HSV-1 UNG enzymes were determined with a series of substrates (Table 1) by fluorescence anisotropy. These included
uracil in both single- and double-stranded DNAs (HU and HUG), the abasic forms of the HU and HUG substrates (HAP and HAP:G), and the non-cleavable substrate
analogs dUrd and  -FdUrd.
Kd
HU HAP HUG HAPG dUrd -FdUrd
M
hUNG
H268N (0.010 4) 104 4.3 0.3 (0.033 9) 103 2.9 0.2 2.0 0.3 1.1 0.1
D145N 1.7 0.7 2.9 0.3 2.6 0.8 2.9 0.7
D145N/H268N (0.016 2) 103 3.5 0.3 (0.130 8) 103 4.5 0.3 3.2 0.2 2.2 0.2
Wild-type 6.9 0.7 9.0 0.8 4.4 0.5 6.3 0.6
HSV-1 UNG
H210N (0.005 7) 104 3.9 0.3 (0.055 5) 103 3.3 0.3 6.1 0.9 1.2 0.2
D88N 4.0 0.3 3.5 0.2 2.0 0.1 1.9 0.1
D88N/H210N (0.008 2) 103 5.6 0.6 (0.068 7) 103 5.3 0.6 4.3 0.2 3.3 0.04
Wild-type 7.2 0.7 8.1 1.6 8.5 0.5 9.4 0.5
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of the base with the active-site pocket of the mutant enzyme and
whether the free nucleotide would adopt the same distorted conforma-
tion in the D88N/H210N mutant enzyme. However, despite efforts to
both soak and co-crystallize the mutant enzyme withrd under a wide
range of conditions, we were unable to obtain a complex. We consider
that the weak binding of the rd oligonucleotide reflects a poor inter-
action of the enzyme with the pseudouracil base and that, for this rea-
son, we were unable to obtain a complex of HSV-1 D88N/H210NUNG
withrd.
DISCUSSION
Implications of the Catalytic Activity of UNG—In this study, the
human and HSV-1 UNG enzymes were compared using a combination
of steady-state kinetics and equilibriumbinding. The steady-state assays
showed that there is a significant difference in the specificity constant
(kcat/Km) for these twoUNG forms (Table 3). Examination of the kinetic
constants showed that the human enzyme has a much lower Km com-
pared with the viral enzyme, resulting in its having a higher specificity
constant.
The Km values that we obtained for hUNG with uracil in single-
stranded DNA (0.22M), the UGmismatch (0.1M), and the UA base
pair (0.12 M) are significantly lower than the previous measurements
of 0.4 and 4.5 M for single-stranded and UA substrates, respectively
(12). These other measures of catalytic constants for hUNG were
obtained upon the release of [3H]uracil in UA base pairs from calf
thymusDNA (8, 12, 13). The somewhat higher kcat values obtained from
this assay (20 s1) may reflect the processivity of the enzyme releasing
FIGURE 4. Binding of wild-type andmutant hUNG enzymes to native DNAs. A, equi-
libriumDNAbinding experimentswere performedwith humanD145N/H268NUNGand
theHU andHUGoligonucleotides by fluorescence anisotropy (see “Materials andMeth-
ods”). The increase in anisotropy for the binding of hUNG to the HU (F) and HUG (Œ)
oligonucleotides is shown plotted against enzyme concentration. Data are shown with
the best fit to the binding equation with the following values: HU, Kd  (0.016  2) 
103M,AD 0.042 0.001, andADE 0.12 0.001; andHUG, Kd (0.130 8) 10
3
M,AD0.0610.001, andADE0.120.001.B, thebindingofwild-typehUNG toHAP
(F) andHAPG (Œ) abasicDNAswasdeterminedby fluorescenceanisotropyand is shown
plotted against enzyme concentration. Data are shown with the best fit to the binding
equation with the following values: HAP, Kd  6.9  0.7 M, AD  0.042  0.001, and
ADE 0.12 0.002; andHAPG, Kd 9.0 0.8M, AD 0.041 0.001, andADE 0.12
0.001.
FIGURE 5.Bindingof thehumanwild-typeandD145N/H268NUNGenzymes tonon-
cleavable substrate analogs drd and -FdUrd. The binding of hexachlorofluores-
cein-labeled oligonucleotides containing the non-cleavable substrate analogs drd
and-FdUrdwasmonitored using fluorescence polarization. A, the binding ofwild-type
hUNGwasmeasuredwith drd (F) and-FdUrd (Œ). Data are shownwith the best fit to
the binding equation with the following values: drd, Kd 4.4 0.5 M, AD 0.041
0.002, and ADE 0.17 0.003; and -FdUrd, Kd 6.3 0.6M, AD 0.039 0.002, and
ADE  0.13  0.002. B, the binding of human D145N/H268N UNG was measured with
drd (F) and-FdUrd (Œ). Data are shownwith the best fit to the binding equationwith
the following values: drd, Kd  3.2  0.2 M, AD  0.038  0.001, and ADE  0.14 
0.001; and -FdUrd, Kd 2.2 0.2 M, AD 0.041 0.003, and ADE 0.17 0.002.
Human and HSV-1 Uracil-DNAGlycosylase
FEBRUARY 24, 2006•VOLUME 281•NUMBER 8 JOURNAL OF BIOLOGICAL CHEMISTRY 4989
 at B
IR
K
B
ECK
 CO
LLEG
E on M
ay 14, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
many uracil bases from the same DNA molecule. The Km values
obtained from this assay range from 0.1 to 4.5M, but vary according to
the conditions used and cannot be related to specific sequences due to
the nature of the assay. These highKm values have led to the proposition
that hUNG acts solely in the post-replicative repair of UAmismatches
(14).
Our previous study with HSV-1 UNG demonstrated that sequence
context can be an important factor in enzyme activity and that varia-
tions in Km of an order of magnitude may be expected, although kcat is
quite insensitive (10). In this study, we used the same AT-rich substrate
that we employed previously, which gave lowerKm values (10). Further-
more, hUNG exhibits no marked preference between UGmismatches
and UA mispairs (Table 3). This is in agreement with previously pub-
lished data suggesting that UNG is more sensitive to the sequence con-
text of uracil than to the partner base of uracil (10).
In principle, kcat/Km provides ameasure of the relative efficiency with
which an enzyme discriminates between two substrates present in the
same reaction mixture (36). The kcat/Km value for hUNG with UG
mismatches (74 M1 s1) is significantly higher than the value for
Xenopus SMUG1with UGmismatches (0.04M1 s1) (37). However,
Xenopus SMUG1 has been shown to be rate-limited by its product dis-
sociation from double-stranded DNA, but Xenopus SMUG1 is stimu-
lated by AP endonuclease, the subsequent enzyme in the base excision
repair pathway (13, 14). The specificity constant may thus not provide
an accurate picture of substrate discrimination in vivo.
A comparison of our Km value for hUNG with UG mismatches (0.1
M) with the Km value for Xenopus SMUG1 with UG mismatches
(0.035 M) shows that there is not a significant difference. Although
Xenopus SMUG1 is evidently capable of removing uracil fromUGmis-
matches from substrates at low concentration (14), our data demon-
strate that there will not be stringent discrimination between UA and
UG substrates by hUNG and Xenopus SMUG1 based on their kinetic
parameters.
A recent study demonstrated that Ung//SMUG2 mouse embry-
onic fibroblast cells aremore sensitive to-radiation comparedwith cell
lines that carry just the individual mutations (38). This clearly indicates
degeneracy in the activity of these two enzymes against a lethal lesion.
The same study also showed that C-to-T mutation frequency is largely,
although not completely, additive. The C-to-T mutation frequency in
Ung/ cells relative to SMUG2 cells indicates that UNG is involved in
the repair of UGmismatches in vivo, whichmight be due to an increase
in deamination during DNA replication. The largely additive response
suggests some specialization for the two enzymes, possibly through
compartmentalization and control (38).
There is evidence for the control of hUNG from its localization at
replication foci (39) and controlled degradation during S phase (40).
However, the high catalytic turnover of hUNG means that, even at
barely detectable levels, it may still be a significant anti-mutator, and
there is evidently no survival disadvantage from degeneracy in DNA
repair systems. The observed control may thus reflect the requirement
to significantly up-regulate repair during DNA replication. Although it
is clear that hUNG has a role in the post-replicative repair of uracil
(39–41), our data support the hypothesis that hUNG will operate on
both UA and UG lesions in vivo and will thus have some overlapping
activity with SMUG1 against UG mismatches and other lesions.
Base Excision by UNG Is Uncoupled from Abasic Site Recognition—
DNAbinding assays demonstrated that the catalytically inactive human
D145N/H268N and HSV-1 D88N/H210N UNG double mutants were
able to bind uracil-containing DNA tightly (Table 4). The crystal struc-
ture of HSV-1 D88N/H210N UNG in complex with uracil shows that
FIGURE 6. Active site of HSV-1 D88N/H210N UNG. A, the amino acid residues in the
active site of HSV-1 D88N/H210N UNG (green, carbons; blue, nitrogen; red, oxygens) are
aligned with those of the wild-type enzyme (purple). Electron density for HSV-1 D88N/
H210NUNG is shown. B, HSV-1D88N/H210NUNGwith uridine bound in the active site is
aligned with the wild-type enzyme with uracil bound in the active site (purple). Electron
density for HSV-1 D88N/H210NUNG is shown. C, hydrogen bond distances between the
residues in the HSV-1 D88N/H210N UNG active site and the bound uracil are shown in
red, whereas those in the active site of the wild-type enzyme are shown in black.
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the base is bound in the active site of the enzyme in exactly the sameway
as it is bound in the wild-type enzyme (Fig. 6, B and C). The specific
interactions between the base and the active-site amino acids remain
unaltered. We therefore conclude that the active-site mutations do not
interfere with substrate binding, but solely with the catalytic
mechanism.
In contrast to the tight binding to the uracil-containing DNA, both
the human and HSV-1 wild-type and mutant UNG enzymes exhibited
100-fold weaker binding to the abasic product DNA (Table 4). These
results contradict those previously obtainedwith hUNGpredicting aba-
sic site protection and coupling to the subsequent base excision repair
machinery (9). This previous study used surface plasmon resonance to
measure DNA binding, whereas we employed a solution-based tech-
nique that is free of many of the deviations that can arise with surface
plasmon resonance. Furthermore, our results (Table 4) are completely
consistent with our previous data obtained with UNG fromHSV-1 (10)
as well as with the observed lack of AP site inhibition with hUNG
(13, 42).
The crystal structures of UNG in complex with uracil show that the
amino acids in the active site of UNG can form a number of interactions
with the bound uracil (Fig. 6C). These interactions are likely to be
responsible for the tight binding of UNG to the uracil-containing DNA.
Consistent with this, the lack of these specific interactions in abasic
productDNAgives rise to the low affinity of UNG forAP sites described
above.
UNGactivity has been shown to increase upon addition of humanAP
endonuclease (HAP-1), suggesting thatHAP-1 promotesAP site release
by UNG and couples the steps of base excision repair (9). However, the
enhancement of UNG activity increases with increasing concentrations
of AP endonuclease up to 50-molar excess, whereas a stoichiometric
amount of HAP-1 does not increase activity. Furthermore, the differ-
ence in activity is more apparent at later reaction time points. Because
UNG is weakly inhibited by abasic DNA in vitro (13, 42), the previously
observed enhancement of UNGactivity byHAP-1 is consistent with the
removal of accumulating AP sites. Our data clearly show that UNG has
a low affinity for abasic sites and that the enzyme has a high turnover
rate, which is inconsistent with AP site protection by UNG. Although
there is a clear appeal to having a coupling of DNA glycosylase and AP
endonuclease activities, we can find no data that support such a theory
for either human or HSV-1 UNG.
DNA Binding and Base Recognition by UNG—Previous crystallo-
graphic studies with hUNG clearly showed the enzyme flipping its tar-
get nucleotide out of the DNA double helix and into the enzyme active
site (8). Our binding data with both human and HSV-1 UNG mutants
demonstrate that it gains a large part of its binding energy from inter-
actions with the uracil base. Furthermore, our crystallographic studies
demonstrated that the double mutant enzyme binds the uracil base in
exactly the same way as the wild-type enzyme. We therefore conclude
that the active-site His and Asp residues do not contribute to uracil
binding, but have a solely catalytic role. The double mutant enzymes
thus provide a sound basis for investigating protein-DNA interactions
of UNG enzymes.
An unexpected finding of this study was the weak binding of both
non-cleavable substrate analogs that we tested: drd and-FdUrd. The
drd analog has been previously used to obtain the structure of an
enzyme-substrate complex (35). In this structure, hUNG is bound to
DNA, with the drd flipped out of the DNAdouble helix into the active
site. The ring of drd is rotated 90° on the glycosidic bond, and C-1
adopts a tetrahedral conformation. This is a highly unusual nucleotide
conformation and led to the proposition that UNG exerts a physical
strain on the substrate, which leads to enhanced electron orbital over-
lap, thus facilitating catalysis (35).
An alternative explanation for the conformation of drd observed in
the complex with UNG is that a tautomerization has taken place, which
leads to sp3-hybridized C-1. It is noteworthy that N-5 of drd becomes
significantly more acidic than N-1 in uracil (43), and this may provide a
mechanism for protonation of C-1. This is an energetically unfavorable
process because it would lead to the loss of aromaticity. However, the
crystals with the drd oligonucleotides took 2 months to grow com-
pared with 1 week for crystals with native DNA (6, 8). It is thus possible
either that this unfavorable tautomer is slowly produced and then cap-
tured by UNG or that the tautomerization is relatively facile and is the
reason for the poor binding that we observed. Our results demonstrate
that caution needs to be used when interpreting experiments with both
drd and -FdUrd because UNG clearly does not behave in the same
way with these base analogs as it does with native uridine.
Conclusion—We have performed a kinetic analysis of both human
and HSV-1 UNG enzymes using oligonucleotide substrates to monitor
both DNA binding and catalytic activity. The striking feature of this
analysis is the similarity of the two enzymes. hUNGhas a notably higher
kcat/Km, suggesting that it is evolutionarily better adapted to removing
minor bases from a large genome. In all other respects, these two
enzymes possess a remarkable similarity in function given their 39%
sequence identity. Considering also the great similarity of their struc-
tures, it seems that the viral enzyme would be a difficult target for spe-
cific therapeutics.
The kinetic parameters that we determined for hUNG also have sig-
nificant implications for the proposed function of this enzyme.We have
demonstrated that hUNG has a low Km and a high kcat/Km for both UA
and UG substrates. We therefore conclude that it is unlikely to be a
specific UA glycosylase in vivo, but that it will most likely have overlap-
ping UG activity with the SMUG1 DNA glycosylase. Furthermore, the
high Kd that we observed for hUNG with abasic DNA suggests that its
activity will be uncoupled from the subsequent common steps of base
excision repair initiated by the AP endonuclease.
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